PMID- 36498595 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20221221 IS - 2077-0383 (Print) IS - 2077-0383 (Electronic) IS - 2077-0383 (Linking) VI - 11 IP - 23 DP - 2022 Nov 28 TI - The Effect of Bariatric Surgery on Circulating Levels of Monocyte Chemoattractant Protein-1: A Systematic Review and Meta-Analysis. LID - 10.3390/jcm11237021 [doi] LID - 7021 AB - Background: MCP-1 (monocyte chemoattractant protein) plays an important role in early phases of atherogenesis as well as in plaque destabilization, which causes cardiovascular events to play an important role in low-grade inflammation. Obesity, particularly extreme obesity, is a pivotal risk factor for atherosclerosis and many other diseases. In the early stages, bariatric surgery might stop or slow atherogenesis by suppressing inflammation, but also in later stages, preventing plaque destabilization. The aim of this meta-analysis was to provide an answer as to whether bariatric surgery has a significant effect on circulating MCP-1 level or not. Methods: A systematic literature search in PubMed, Scopus, Embase, and Web of Science was performed from inception to 1 January 2022. Meta-analysis was performed using Comprehensive Meta-Analysis (CMA) V2 software. In order to heterogeneity compensation of studies in terms of study design and treatment duration, the characteristics of the studied populations random-effects model and the generic inverse variance weighting method were used. To investigate the relationship with the estimated effect size, a random-effect meta-regression model was used. To assess the exitance of publication bias in the meta-analysis, the funnel plot, Begg's rank correlation, and Egger's weighted regression tests were used. Results: Meta-analysis of 25 studies with 927 subjects included demonstrated a significant decrease of MCP-1 concentration after bariatric surgery. The data of meta-regression did not indicate any association between the alterations in body mass index (BMI) and absolute difference in MCP-1 levels, but a linear relationship between the changes in MCP-1 and length of follow-up was proven. Conclusions: Bariatric surgery significantly decreases MCP-1 concentration, but there was no association between the changes in BMI and absolute difference in MCP-1 levels before and after the surgery. FAU - Jamialahmadi, Tannaz AU - Jamialahmadi T AD - Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. AD - Surgical Oncology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. FAU - Abbasifard, Mitra AU - Abbasifard M AD - Immunology of Infectious Diseases Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran. AD - Department of Internal Medicine, Ali-Ibn Abi-Talib Hospital, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran. FAU - Reiner, Zeljko AU - Reiner Z AD - Department of Internal Medicine, University Hospital Center Zagreb, 10000 Zagreb, Croatia. FAU - Kesharwani, Prashant AU - Kesharwani P AUID- ORCID: 0000-0002-0890-769X AD - Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, India. AD - Center for Transdisciplinary Research, Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Science, Chennai 602105, India. FAU - Sahebkar, Amirhossein AU - Sahebkar A AUID- ORCID: 0000-0002-8656-1444 AD - Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. AD - Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran. AD - Department of Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. LA - eng PT - Journal Article DEP - 20221128 PL - Switzerland TA - J Clin Med JT - Journal of clinical medicine JID - 101606588 PMC - PMC9738353 OTO - NOTNLM OT - atherosclerosis OT - bariatric surgery OT - cardiovascular disease OT - meta-analysis OT - monocyte chemoattractant protein-1 OT - obesity COIS- The authors declare no conflict of interest. EDAT- 2022/12/12 06:00 MHDA- 2022/12/12 06:01 PMCR- 2022/11/28 CRDT- 2022/12/11 01:14 PHST- 2022/10/06 00:00 [received] PHST- 2022/11/18 00:00 [revised] PHST- 2022/11/24 00:00 [accepted] PHST- 2022/12/11 01:14 [entrez] PHST- 2022/12/12 06:00 [pubmed] PHST- 2022/12/12 06:01 [medline] PHST- 2022/11/28 00:00 [pmc-release] AID - jcm11237021 [pii] AID - jcm-11-07021 [pii] AID - 10.3390/jcm11237021 [doi] PST - epublish SO - J Clin Med. 2022 Nov 28;11(23):7021. doi: 10.3390/jcm11237021.